Navigation Links
Clinical Genomics & Informatics Europe Announce New Keynotes & Final Program
Date:8/6/2013

Needham, MA (PRWEB) August 06, 2013

Bio-IT World and Cambridge Healthtech Institute today announced the final program and keynote lineup for the Fifth International Clinical Genomics & Informatics Europe Conference. The three-day event will be held 4-6 December 2013 in Lisbon, Portugal and will bring together the international science and informatics communities to discuss the latest strategies for analyzing, interpreting and implementing the huge amounts of sequencing data now available. Keynote presenters include Dr. Anne Cambon-Thomsen of Centre National de la Recherche Scientifique, Dr. Niklas Blomberg of ELIXIR, Dr. Timothy Hubbard of Wellcome Trust Sanger Institute, and Dr. Hans-Hilger Ropers of the Max Planck Institute for Molecular Genetics.

Dr. Anne Cambon-Thomsen, Research Director of Centre National de la Recherche Scientifique, currently leads an interdisciplinary research team on genomics, biotherapies and public health. She is heavily involved in several EU projects, advisory boards and associations in genomic sciences, public health and biobanking and serves on the national birth cohort ELFE as president. Dr. Cambon-Thomsen will present "The Ethical Dimensions of Data Sharing and the Maze of Identifiability."

Founding Director of ELIXIR: The European Research Instrastructure for Life Science Data, Dr. Niklas Blomberg, will share new efforts for storing, integrating and analyzing data with ELIXIR's e-infrastructure. Dr. Blomberg holds a Ph.D. from the European Molecular Biology Laboratory and plays an active role in advancing industry research as a national e-Science advisor. Prior to joining ELIXIR, Dr. Blomberg was responsible for creating AstraZeneca’s cross-disciplinary computational chemistry team in support of respiratory, inflammation and autoimmune research.

As the Head of Human Genome Analysis at Wellcome Trust Sanger Institute and Advisor to NHS England’s 100,000 Genome Project, Dr. Timothy Hubbard has been a lead advisor for a multitude of research initiatives, including the advisory council of the RIKEN Genomic Sciences Center, the Expert Group on European research infrastructure for genomics, bioinformatics, animal resources, proteomics, and structural biology of the European Strategy Forum for Research Infrastructures, the advisory board of UK PubMedCentral, the steering group of the National Genetics Reference Laboratories and the E-Health Records Research Board of the UK Government Office for Strategic Coordination of Health Research. Dr. Hubbard holds a Ph.D. in Protein Design from the Department of Crystallography, Birkbeck College. Dr. Hubbard will deliver a timely presentation on how to implement whole genome sequencing.

Dr. Hans-Hilger Ropers is the Director at the Max Planck Institute for Molecular Genetics and Honorary Professor for Human Genetics at Humboldt University. He also heads the Biomedical Class of the Berlin-Brandenburg Academy of Sciences. During his time at the Max Planck Institute, Dr. Ropers’ team has successfully employed positional cloning and related strategies to elucidate molecular defects underlying various genetic disorders, including inherited forms of blindness, deafness and mental retardation. Dr. Ropers will discuss the importance of new sequencing techniques and opportunities for speeding their clinical implementation.

This year’s event will feature four main tracks on Clinical Exome Sequencing, High-Scale Computing, RNA Sequencing and Transcriptome Analysis, and Genome Informatics. In addition, two pre-conference Symposia will be held on Tuesday, 3 December on Clinical Epigenetics and Digital Detection Techniques and Applications.

Each conference track offers interactive discussion, networking and Q&A sessions to maximize audience participation. Attendees also have the opportunity to submit a research poster to be displayed to the international delegation of life science, pharmaceutical, clinical, healthcare, and IT professionals.

To view the final program and speaking faculty, visit http://www.clinicalgenomicsinformatics.com

About Bio-IT World

Bio-IT World (http://www.bio-itworld.com) is a leading source of news and opinion on technology and strategic innovation in the life sciences, including drug discovery, development and clinical trials. Bio-IT World's focus explores themes at the intersection of IT and biomedical research, including big data, next-generation technologies, innovative informatics, and software tools, pushing towards a new era of precision medicine. The group also produces a variety of e-newsletters, web alerts, web symposia, podcasts, topic-specific briefings, white papers, and the Bio-IT World Best Practices Awards. In addition to the flagship Bio-IT World Expo in Boston, the group also organizes conferences in Europe and Asia, an annual West Coast Symposium, and co-produces The Clinical Genome Conference. Established in 2001, Bio-IT World has been published by Cambridge Healthtech Institute since 2006. It is based in Needham, Mass.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute (CHI) (http://www.chicorporate.com), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10998707.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Three Executives from inVentiv Health Clinical and Communications Recognized on Prestigious List of PharmaVOICE 100 Industry Leaders
2. inVentiv Health Clinical Expands and Strengthens Executive Team with Three Strategic Appointments
3. SynteractHCR Senior Director of Clinical Operations Mary Clegg Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences
4. Clinovo Presents Its Paper ‘Cloud for Clinical Trials’ at Society for Clinical Data Management (SCDM) Conference 2013
5. SureClinical Completes FDA 21 CFR Part 11 Compliance Audit of SureTrial® eTMF Cloud Edition
6. Gallus BioPharmaceuticals Enters Clinical Supply Agreement with Genzyme for Niemann-Pick Type B Disease
7. Celladon Corporation Announces Pre-clinical Study Demonstrating Inhalable MYDICAR Reverses Pulmonary Arterial Hypertension (PAH)
8. AACCs New Online Tool Could Revolutionize How Students Prepare for Clinical Board Examinations
9. GlycoVaxyn AG secures CHF 5.1 million Strategic Translation Award from the Wellcome Trust to finance clinical development of Shigella vaccine
10. Express Diagnostics Introducing New Products and Expanded Catalog of Drug Tests at the 2013 AACC Clinical Lab Expo
11. New study refutes existence and clinical potential of very small embryonic-like stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... Participants of ... a high-performance fume hood. Along with the advantages and disadvantages of ductless, filtered ... ducted hoods in the laboratory. , Attendees will learn from an industry expert ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... an biological outbreak is about to be eliminated, said Lyle Probst, President, CEO ... FireflyDX™ technologies different than other pathogen detection solutions, Probst said, “Sample ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... DFS) cybersecurity regulations have transitioned into full force and effect. The law ... state (“Covered Entities”) to conduct an annual, professional, comprehensive cybersecurity risk assessment, ...
(Date:9/18/2017)... --  Montrium , a growing leader in Electronic Trial Master ... groundbreaking non-profit research organization, Multidisciplinary Association for Psychedelic Studies (MAPS). ... MAPS Public Benefit ... ... to MDMA for the treatment of Posttraumatic Stress Disorder (PTSD). MAPS ...
Breaking Biology Technology:
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
Breaking Biology News(10 mins):